Online Monitors (OMO) - Details

The Online Monitor (OMO) is the continuous documentation of patients with the indications Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Prostate Cancer, Head and Neck Tumours, Renal Carcinoma, Non-Hodgkin Lymphoma (NHL), Ovarian Cancer, Brain Tumours, Haematological Diseases, Rheumatoid Arthritis, HIV, Diabetes, Cardiovascular Diseases, CNS Diseases, Nephrological Diseases.

The specialized physicians enter online, the details of the treatments for all of their patients for the afore-mentioned indications. If a patient's treatment has been documented previously, the past and present treatment details will be updated by the respondent during the next cycle of the monitor.

The OMO captures the key treatment details for each patient, allowing you to examine, in real time, the overview of the market for different market segments using our online reporting tool. For example, one of the OMO's specialised features is its ability to report therapy sequences (for example, proportion of 2nd or 3rd line therapy from a defined 1st line therapy), all in real time. As soon as a respondent enters new patient data, and once this information has passed the quality checks, this information is available instantly in the OMO reporting tool.

You can also download fully-customisable reports. We would also be able to provide you with defined reports at regular intervals on the status of the monitor fieldwork, the results, the outcomes, etc.

The OMO will provide you with the background data for your market analyses and sales forecasts, enabling you to actively monitor the impact of your marketing strategies directly in the market.